Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 89 (3) , 378-390
- https://doi.org/10.1016/0041-008x(87)90157-8
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Modulation of stromal cell function in DBA/2J and B6C3F1 mice exposed to benzene or phenolToxicology and Applied Pharmacology, 1985
- Cultured Human Alveolar Macrophages From Smokers With Lung Cancer: Resolution of Factors That Stimulate Fibroblast Proliferation, Production of Collagenase, or Prostaglandin E2Journal of Leukocyte Biology, 1985
- Characterization of the benzene monooxygenase system in rabbit bone marrowBiochemical Pharmacology, 1984
- In vitro effects of benzene metabolites on mouse bone marrow stromal cellsToxicology and Applied Pharmacology, 1984
- Inhibition of erythropoiesis by benzene and benzene metabolitesToxicology and Applied Pharmacology, 1983
- Decreased hepatic microsomal cytochrome P450 due to indomethacin: Protective roles of 16,16-dimethylprostaglandin F2α and inducing agentsBiochemical Pharmacology, 1983
- Effect of in vivo exposure to benzene on the characteristics of bone marrow adherent cellsLeukemia Research, 1983
- 3H-Benzene metabolism in rabbit bone marrowLife Sciences, 1979
- Prostaglandins and drug induced agranulocytosis, aplastic anaemia and leukemiaProstaglandins and Medicine, 1979
- The problem of benzene in our environmentThe Lancet Healthy Longevity, 1978